Can the Microenvironment Be Targeted for Cancer Therapy?
Yes, targeting the cancer microenvironment is a promising strategy for cancer therapy. By disrupting the supportive environment for the tumor, therapies can potentially inhibit tumor growth and metastasis. Some strategies include anti-angiogenic therapies, immune checkpoint inhibitors, and drugs targeting stromal components such as fibroblasts and the ECM. These therapies aim to make the microenvironment less conducive to cancer cell survival and proliferation.
